TR-701FA Tedizolid Phosphate Torezolid Cas 856867-55-5
TR-701FA Tedizolid Phosphate Torezolid Cas 856867-55-5
| Product name:TR-701FA Tedizolid Phosphate | Purity:99.8%min |
| CAS NO:856867-55-5 | Solubility:DMSO : ≥ 36 mg/mL (79.94 mM) |
| Molecular Formula:C17H18FN6O7P | Package:Package according to customer requirements |
| Molecular Weight:450.32 | Storage:Store at -20℃ |
Tedizolid phosphate, also know as TR-701FA tedizolid, torezolid (trade name Sivextro), is an oxazolidinone drug being developed by Cubist Pharmaceuticals following acquisition of Trius Therapeutics (originator: Dong-A Pharmaceuticals) for complicated skin and skin-structure infections (cSSSIs), including those caused by methicillin-resistant Staphylococcus aureus (MRSA). Tedizolid has been approved by the FDA on June 20, 2014, for the treatment of MRSA skin infections.
Related Prodcuts:
Tedizolid intermediate 1; Tedizolid intermediate 2; Torezolid intermediate 3; Tedizolid intermediate H; Tedizolid Impurity; Tedizolid
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.